» Articles » PMID: 24566009

Hepatitis C Virus (HCV)-specific Memory B-cell Responses in Transiently and Chronically Infected HIV Positive Individuals

Overview
Journal J Clin Virol
Specialty Microbiology
Date 2014 Feb 26
PMID 24566009
Citations 4
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Antibody responses to hepatitis C virus (HCV) occur delayed and overly decline after viral clearance indicating that the B-cell response to HCV is abnormal. Virus-specific memory B-cells have recently been found in infected individuals, but the viral exposure requirements for the generation of these cells is unknown.

Objectives: The primary goal of this study was to quantify and compare the HCV-specific memory B-cell response between chronic and resolved HCV-infected individuals. A secondary goal was to examine if HIV-specific memory B-cell responses are maintained during HCV co-infection.

Study Design: HCV core protein- and HIV-specific memory B-cell responses were examined in HIV/HCV-infected individuals treated 4-30 weeks after HCV diagnosis. Memory B-cell frequencies were compared between chronically and transiently infected individuals.

Results: Chronically infected individuals had vigorous HCV-specific memory B-cell responses and antibodies, whereas subjects with transient viremia showed low or undetectable virus-specific B-cell responses. In addition, chronically HIV/HCV-infected subjects had robust HIV-specific memory B-cell responses.

Conclusions: Whereas chronic HCV infection induces virus-specific antibodies and memory B-cells, transient infection in individuals with sustained viral response to therapy does not stimulate a durable HCV-specific B-cell response indicating that the formation of long-lived virus-specific B-cells is suppressed in the early phase of infection. This may contribute to the inability to spontaneously clear HCV infection.

Citing Articles

Stimulation of B Cell Immunity in Flavivirus-Naive Individuals by the Tetravalent Live Attenuated Dengue Vaccine TV003.

Tu H, Nivarthi U, Graham N, Eisenhauer P, Delacruz M, Pierce K Cell Rep Med. 2020; 1(9):100155.

PMID: 33377126 PMC: 7762770. DOI: 10.1016/j.xcrm.2020.100155.


Evaluation of immunological indices in HIV-infected patients with chronic hepatitis C in Kazakhstan.

Sarsekeyeva N, Kosherova B Int J Gen Med. 2016; 9:147-53.

PMID: 27284263 PMC: 4883804. DOI: 10.2147/IJGM.S101303.


Comparative Immunogenicity in Rabbits of the Polypeptides Encoded by the 5' Terminus of Hepatitis C Virus RNA.

Sominskaya I, Jansons J, Dovbenko A, Petrakova N, Lieknina I, Mihailova M J Immunol Res. 2015; 2015:762426.

PMID: 26609538 PMC: 4644844. DOI: 10.1155/2015/762426.


High Inter-Individual Diversity of Point Mutations, Insertions, and Deletions in Human Influenza Virus Nucleoprotein-Specific Memory B Cells.

Reiche S, Dwai Y, Bussmann B, Horn S, Sieg M, Jassoy C PLoS One. 2015; 10(6):e0128684.

PMID: 26086076 PMC: 4472751. DOI: 10.1371/journal.pone.0128684.